Replimune Group, Inc. (REPL)
8.41
+0.80
(+10.51%)
USD |
NASDAQ |
Apr 02, 16:00
8.42
+0.01
(+0.12%)
After-Hours: 20:00
Replimune Group Total Assets (Quarterly) : 333.59M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.440B |
| Phathom Pharmaceuticals, Inc. | 259.80M |
| REGENXBIO, Inc. | 453.03M |
| Corcept Therapeutics, Inc. | 838.03M |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.05M |
| Shareholders Equity (Quarterly) | 210.54M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |